These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Nerve growth factor and dexamethasone specify the catecholaminergic phenotype of cultured rat chromaffin cells: dependence on developmental stage. Author: Grothe C, Hofmann HD, Verhofstad AA, Unsicker K. Journal: Brain Res; 1985 Jul; 353(1):125-32. PubMed ID: 4027676. Abstract: Antibodies to epinephrine (E) and bovine phenylethanolamine N-methyltransferase (PNMT) have been used to monitor the regulation of the E- and PNMT-immunoreactive chromaffin cell phenotypes by dexamethasone (DEX) and nerve growth factor (NGF). The cells were isolated from 1-, 10- and 30-day-old (D1, D10 and D30) rat adrenal glands and grown for 4 days on a polyornithine substratum. DEX (10(-5)M) supported the survival of 90% of the cells from all postnatal ages studied. In contrast, only 45% (D1), 33% (D10) and 60% (D30) of the chromaffin cells had survived after 4 days in control cultures or when treated with NGF (100 ng/ml). Throughout this study numbers of E-immunoreactive cells were approximately 10% larger than those of cells stained by anti-PNMT antibodies irrespective of the treatments applied. 55% of the cells isolated at D1 and 79% of the cells at D10 were stained by anti-E antibodies. The proportion of E-positive cells was constant in D1 cultures carried for 4 days, while E-immunoreactive cells dropped to 63% in cultures from D10. At D1 and D10 DEX and NGF had opposite effects on the portions of E-positive cells, DEX increasing and NGF decreasing their relative numbers, 66% of the chromaffin cells isolated at D30 displayed E-specific immunoreactivity. DEX caused a significant increase (to 74%), while both NGF-treated and control cultures exhibited a decrease in the relative numbers of E-immunoreactive cells.(ABSTRACT TRUNCATED AT 250 WORDS)[Abstract] [Full Text] [Related] [New Search]